ADMA Biologics Ownership | Who Owns ADMA Biologics?
ADMA Biologics Ownership Summary
ADMA Biologics is owned by 15.58% institutional investors, 2.74% insiders, and 81.67% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 15.23% of ADMA shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.05% of its assets in ADMA Biologics shares.
ADMA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ADMA Biologics | 15.58% | 2.74% | 81.67% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 36.33M | 15.23% | $662.72M |
| Vanguard group | 20.85M | 8.74% | $380.39M |
| Blackrock | 18.64M | 8.15% | $208.45M |
| State street | 13.56M | 5.62% | $198.81M |
| Invesco | 12.51M | 5.18% | $183.33M |
| Sachem head capital management lp | 8.96M | 3.71% | $131.35M |
| Westfield capital management co lp | 6.99M | 2.93% | $127.55M |
| Capital research global investors | 6.64M | 2.78% | $121.07M |
| Nuveen | 5.93M | 2.48% | $108.10M |
| Geode capital management | 5.83M | 2.44% | $106.37M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| B group | 2.41M | 26.02% | $35.37M |
| Stonepine capital management | 739.00K | 8.81% | $10.83M |
| Caligan partners lp | 2.64M | 5.06% | $38.65M |
| Awm investment company | 2.20M | 3.88% | $40.13M |
| Sachem head capital management lp | 8.96M | 3.71% | $131.35M |
| Ranger investment management | 2.30M | 2.88% | $41.97M |
| Ophir asset management pty | 1.26M | 2.27% | $18.40M |
| Catalio capital management, lp | 684.51K | 1.86% | $10.03M |
| Marathon capital management | 465.31K | 1.83% | $8.49M |
| Oberweis asset management inc/ | 2.71M | 1.52% | $39.76M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sachem head capital management lp | 8.96M | 3.71% | 8.96M |
| Capital research global investors | 6.64M | 0.02% | 3.38M |
| Caligan partners lp | 2.64M | 5.06% | 2.64M |
| Ubs group | 4.57M | 0.01% | 2.58M |
| Westfield capital management co lp | 6.99M | 0.53% | 1.89M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 732.66K | 0.00% | -2.48M |
| Driehaus capital management | - | - | -2.48M |
| D. e. shaw | 3.07M | 0.04% | -2.20M |
| Perpetual | - | - | -2.12M |
| Nuveen asset management | 4.55M | 0.02% | -2.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sachem head capital management lp | 8.96M | 3.71% | 8.96M | $131.35M |
| Caligan partners lp | 2.64M | 5.06% | 2.64M | $38.65M |
| Pfm health sciences, lp | 1.18M | 1.33% | 1.18M | $17.31M |
| William blair investment management | 890.86K | 0.05% | 890.86K | $16.25M |
| Boothbay fund management | 773.16K | 0.16% | 773.16K | $11.33M |
Sold Out
| Holder | Change |
|---|---|
| Mendota financial group | -4.00 |
| True wealth design | -11.00 |
| Huntington national bank | -14.00 |
| Global financial private client | -24.00 |
| Aquatic capital management | -27.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | -68.06% | 37,183,315 | -83.04% | 15 | 0.19% | 65 | -60.37% | 34 | -78.48% |
| Sep 30, 2025 | 154 | -58.93% | 47,734,498 | -76.76% | 19 | 0.27% | 60 | -74.36% | 68 | -33.98% |
| Jun 30, 2025 | 376 | 4.16% | 204,872,171 | 0.17% | 84 | 1.15% | 230 | 18.56% | 107 | -6.96% |
| Mar 31, 2025 | 357 | 8.51% | 204,309,752 | 0.18% | 85 | 1.14% | 192 | -4.00% | 113 | 9.71% |
| Dec 31, 2024 | 321 | 3.55% | 200,305,365 | -3.74% | 85 | 1.09% | 196 | 1.55% | 99 | 2.06% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 14.41M | 6.05% | 14.41M |
| Vanguard Total Stock Mkt Idx Inv | 7.19M | 3.02% | 19.12K |
| Vanguard US Total Market Shares ETF | 7.15M | 3.01% | 281.42K |
| iShares Russell 2000 ETF | 5.58M | 2.34% | 1.62M |
| American Funds SMALLCAP World A | 5.30M | 2.22% | 2.98M |
| State Street® SPDR® S&P® Biotech ETF | 5.02M | 2.11% | -26.87K |
| SPDR® S&P Biotech ETF | 3.25M | 1.36% | 7.24K |
| American Century U.S. Small Cap Growth | 3.16M | 1.33% | - |
| American Century Small Cap Growth Inv | 3.16M | 1.33% | - |
| Xtrackers MSCI World Swap ETF 1C | 2.97M | 1.24% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 09, 2026 | Kestenberg-Messina Kaitlin M. | COO and SVP, Compliance | Sell | $157.80K |
| Mar 06, 2026 | ELMS STEVE | - | Buy | $107.73K |
| Mar 05, 2026 | ELMS STEVE | - | Buy | $109.69K |
| Feb 17, 2026 | Grossman Adam S | President and CEO | Sell | $96.48K |
| Feb 17, 2026 | Grossman Adam S | President and CEO | Sell | $241.20K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 2 | 3 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 13 |
| 2025 Q1 | - | 2 |
ADMA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools